Is tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction?

Keyphrases

• Microvascular Breast Reconstruction 100%
• Thromboembolic Complications 100%
• Complication Rate 60%
• Thromboembolic Events 60%
• Flap Loss 40%
• Overall Complications 40%
• Minor Complications 40%
• Major Complications 20%
• Adjuvant Therapy 20%
• Breast Reconstruction 20%
• Thrombus Formation 20%
• Retrospective Review 20%
• Anastomotic Site 20%
• Pulmonary Embolism 20%
• Timing of Surgery 20%
• Autologous Tissue 20%
• Third Generation 20%
• Anastrozole 20%
• Flap Complications 20%
• Aromatase Inhibitors 20%
• DIEP Flap 20%
• Exemestane 20%
• Hormone Receptor-positive Breast Cancer 20%
• Letrozole 20%
• TRAM Flap 20%

Medicine and Dentistry

• Inpatient 100%
• Tamoxifen 100%
• Thromboembolism 100%
• Breast Reconstruction 100%
• Complication 88%
• Patient 66%
• Graft Failure 22%
• Microsurgery 22%
• Tissues 11%
• Association 11%
• Breast Cancer 11%
• Surgery 11%
• Hormone Receptor 11%
• Adjuvant Therapy 11%
• Blood Clotting 11%
• Surgical Anastomosis 11%
• Pulmonary Embolism 11%
• Transverse Rectus Abdominis Musculocutaneous Flap 11%
• Exemestane 11%
• Deep Inferior Epigastric Perforator Flap 11%
• Anastrozole 11%
• Letrozole 11%
• Aromatase Inhibitor 11%

INIS

• patients 100%
• risks 100%
• breasts 100%
• tamoxifen 100%
• losses 20%
• cancer 10%
• tissues 10%
• hormones 10%
• comparative evaluations 10%
• receptors 10%
• therapy 10%
• reviews 10%
• surgery 10%